Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cempra
Cempra
These five biotech CEOs earned big bucks even as their companies tanked
Stat
Fri, 05/5/17 - 10:33 am
biotech
executive pay
Seres Therapeutics
Pacira
Ophthotech
Cempra
Endo International
Top Biopharma Movers of the Past Week
Yahoo/24-7 Wall St
Sun, 02/26/17 - 01:05 pm
EyeGate Pharma
Trevena
Valeant Pharmaceuticals
Cempra
Biotech's Top 3 Stock Losers, and Winners, in 2016
Forbes
Mon, 01/2/17 - 12:03 pm
biotech
Concordia
Ophthotech
Cempra
Corbus Pharmaceuticals
CoLucid
AveXis
Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study
Endpoints
Thu, 12/29/16 - 10:12 am
FDA
Cempra
antibiotics
Solithromycin
Cempra Rises on Late-Stage Trial
Yahoo/24-7 Wall St
Mon, 12/5/16 - 09:57 am
Cempra
clinical trials
Solithromycin
community acquired bacterial pneumonia
Will FDA approve a new antibiotic despite ‘significant’ safety issues?
Stat/Pharmalot
Mon, 11/7/16 - 09:14 pm
FDA
antibiotics
Solithromycin
Cempra
FDA panel narrowly backs Cempra antibiotic
Yahoo/AP
Sat, 11/5/16 - 09:26 am
FDA
advisory panels
Cempra
antibiotics
Solithromycin
Cempra shares plummet ahead of FDA meeting on antibiotic
Yahoo/AP
Wed, 11/2/16 - 10:20 pm
Cempra
FDA
antibiotics
Solithromycin
Cempra Releases Promising Phase II Clinical Trial Results For Anti-NASH Drug
Xtalks
Wed, 10/5/16 - 05:25 pm
Cempra
clinical trials
NASH
liver disease
Solithromycin
Could Cempra's Solithromycin Become The Largest Selling Antibiotic In History?
Seeking Alpha
Mon, 09/5/16 - 10:02 am
Cempra
Solithromycin
antibiotics
community acquired bacterial pneumonia
Chapel Hill drug developer Cempra looks to raise $200M
Bizjournals.com
Wed, 01/6/16 - 07:58 pm
Cempra
R&D
How a Chapel Hill drug developer almost doubled its value in two months
Bizjournals.com
Tue, 12/8/15 - 11:21 am
Cempra
Cempra’s New Drug Holds Potential, but Risk for Investors
TheStreet.com
Fri, 10/30/15 - 11:14 am
Cempra
Solithromycin
FDA
antibiotics
3 Biotech Stocks to Buy With Huge Catalysts Coming Soon
24/7 Wall St
Mon, 08/3/15 - 12:17 pm
Biomarin
drisapersen
Cempra
Solithromycin
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Chapel Hill drug developer Cempra sees stock bounce on pneumonia trial
Bizjournals.com
Tue, 07/7/15 - 10:30 am
Cempra
community acquired bacterial pneumonia
Solithromycin
2 Biotech Buyout Candidates as Antibiotics Stop Working
24/7 Wall St
Mon, 05/4/15 - 09:39 am
biotech
antibiotics
antibiotic resistance
Tetraphase Pharmaceuticals
Cempra
Japanese patent to infuse $10M into Chapel Hill drug developer
Bizjournals.com
Mon, 04/27/15 - 09:54 am
Japan
patents
Cempra
CABP
community acquired bacterial pneumonia
Toyama
Analyst’s Top 3 Biotech Picks for 2015 With Upside and Takeover Potential
24/7 Wall St
Fri, 01/9/15 - 10:44 am
M&A
Cempra
Jazz Pharmaceuticals
Kite Pharma
Cempra Oral Antibiotic Effective Against Hard-to-Treat Pneumonia
TheStreet.com
Mon, 01/5/15 - 09:10 am
Cempra
antibiotics
Solithromycin
community acquired bacterial pneumonia
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Biogen Idec
Bluebird Bio
Arrowhead Research
Vertex Pharmaceuticals
Cempra
CTI BioPharma
Gilead Sciences
Merck
Bristol-Myers Squibb
Sarepta Therapeutics
Neurocrine Biosciences
Pages
1
2
3
next ›
last »